Amy Garabedian
General Counsel bij LAVA THERAPEUTICS N.V.
Vermogen: 224 772 $ op 31-03-2024
Actieve functies van Amy Garabedian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| LAVA THERAPEUTICS N.V. | General Counsel | 27-07-2021 | - |
| Corporate Secretary | 27-07-2021 | - |
Loopbaan van Amy Garabedian
Eerdere bekende functies van Amy Garabedian
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01-09-2015 | 01-05-2020 |
Ballard Spahr LLP
 Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | General Counsel | - | - |
Opleiding van Amy Garabedian
| Temple University (Pennsylvania) | Graduate Degree |
| The Pennsylvania State University | Undergraduate Degree |
| Widener University Delaware Law School | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Nederland | 2 |
Operationeel
| General Counsel | 2 |
| Graduate Degree | 2 |
| Corporate Secretary | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| LAVA THERAPEUTICS N.V. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Ballard Spahr LLP
Ballard Spahr LLP Miscellaneous Commercial ServicesCommercial Services Ballard Spahr LLP provides legal services. It also provides counsel in litigation, business and finance, real estate, intellectual property, and public finance. The company was founded in 1885 and is headquartered in Philadelphia, PA. | Commercial Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Beurs
- Insiders
- Amy Garabedian
- Ervaring
